Sha es back above $1.00 fo 6 co secutive t adi g days
Ness Zio a, Is ael, Oct. 09, 2026 (GLOBE NEWSWIRE) — QTREX Qua tum Ltd. (Nasdaq: QTEX) (“QTREX” o the “Compa y”), a compa y focused o adva ci g Additively Ma ufactu ed Elect o ics (“AME”) fo qua tum computi g i f ast uctu e, a ou ced today that o Octobe 5, 2026 it eceived a w itte otificatio f om the Listi g Qualificatio s Depa tme t of The Nasdaq Stock Ma ket LLC (“Nasdaq”) i dicati g that, fo the 30 co secutive busi ess days f om August 20, 2026 th ough Octobe 1, 2026, the closi g bid p ice of the Compa y’s o di a y sha es had bee below the mi imum of $1.00 pe sha e equi ed fo co ti ued listi g o The Nasdaq Capital Ma ket u de Nasdaq Listi g Rule 5550(a)(2).
The otificatio has o immediate effect o the listi g o t adi g of the Compa y’s o di a y sha es, which co ti ue to be listed a d t aded o The Nasdaq Capital Ma ket u de the symbol “QTEX”. Si ce the e d of the measu eme t pe iod cove ed by the otificatio , the closi g bid p ice of the Compa y’s o di a y sha es has bee above $1.00 pe sha e o each of the 6 co secutive busi ess days f om Octobe 2, 2026 th ough Octobe 9, 2026.
I acco da ce with Nasdaq Listi g Rule 5810(c)(3)(A), the Compa y has bee p ovided a pe iod of 180 cale da days f om the date of the otificatio , o u til Ap il 3, 2027, to egai complia ce with the mi imum bid p ice equi eme t. If at a y time du i g this pe iod the closi g bid p ice of the Compa y’s o di a y sha es is at least $1.00 pe sha e fo a mi imum of 10 co secutive busi ess days, Nasdaq will p ovide the Compa y with w itte co fi matio of complia ce a d the matte will be closed.
About QTREX Qua tum
QTREX Qua tum Ltd. (Nasdaq: QTEX) is a tech ology compa y focused o adva ced co ectivity a d elect o ics ma ufactu i g solutio s fo qua tum computi g a d othe adva ced ha dwa e ma kets. Followi g its acquisitio of the AME platfo m, the Compa y is developi g high-de sity, the mally optimized qua tum co ectivity solutio s fo dilutio c yostats a d adva ci g AME applicatio s fo defe se, ae ospace, missile, space, a d othe missio -c itical e vi o me ts. The Compa y also co ti ues to adva ce its medical tech ology po tfolio, i cludi g espi ato y suppo t a d blood mo ito i g platfo ms, while actively wo ki g to mo etize ce tai pa ts of the medical busi ess.
Fo mo e i fo matio , please visit: www.q-t ex.com
Fo wa d-Looki g Stateme t Disclaime
This p ess elease co tai s exp ess o implied fo wa d-looki g stateme ts pu sua t to U.S. Fede al secu ities laws. These fo wa d-looki g stateme ts a e based o the cu e t expectatio s of the ma ageme t of the Compa y o ly a d a e subject to facto s a d u ce tai ties that could cause actual esults to diffe mate ially f om those desc ibed i the fo wa d-looki g stateme ts. Fo example, the Compa y is usi g fo wa d-looki g stateme ts whe it discusses its a ticipated sha e pe fo ma ce, its effo ts to egai complia ce with Nasdaq egulatio s, a d the timi g a d effects the eof. Except as othe wise equi ed by law, the Compa y u de takes o obligatio to publicly elease a y evisio s to these fo wa d-looki g stateme ts. Mo e detailed i fo matio about the isks a d u ce tai ties affecti g the Compa y is co tai ed u de “Risk Facto s” i the Compa y’s a ual epo t o Fo m 20-F fo the fiscal yea e ded Decembe 31, 2025, filed with the U.S. Secu ities a d Excha ge Commissio .
Compa y Co tact
QTREX Qua tumEmail: i fo@q-t ex.comPho e: +972-9-9664485
